Fig. 2From: Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phaseTornado diagram showing the impact of each varying parameter on the ICER in the modelBack to article page